awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38091754-A902D14D-BB5D-47B3-B753-8CB510303D3B
Q38091754-A902D14D-BB5D-47B3-B753-8CB510303D3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38091754-A902D14D-BB5D-47B3-B753-8CB510303D3B
Anti-IgE--emerging opportunities for Omalizumab.
P2860
Q38091754-A902D14D-BB5D-47B3-B753-8CB510303D3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38091754-A902D14D-BB5D-47B3-B753-8CB510303D3B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b2eea2e813ccb9fcf3afe0462641c957aad64432
P2860
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis.